Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07192055

Self-sampling to Optimize Anal Lesion Outcomes

Self-sampling to Optimize Anal Lesion Outcomes (SOLO)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
572 (estimated)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSelf-samplingSelf-sampling instructions will be provided to participants who will insert the swab into the anus to collect cells. Then the participant will put the swab in a vial of transport fluid for assessment at a laboratory.
OTHERNylon-flocked SwabAt the cytology appointment, participants may receive self-sampling or clinician sampling with 1 of 2 kinds of swabs. The nylon-flocked swab is the intervention and will be assessed on patient acceptability and patient and clinician ability to collect an adequate sample.

Timeline

Start date
2025-11-18
Primary completion
2028-03-31
Completion
2029-03-31
First posted
2025-09-25
Last updated
2026-04-16

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07192055. Inclusion in this directory is not an endorsement.